Biopharma / Medtech Reports

November 18, 2025

IRTC Coverage Risks: Smoke or Fire?

•

John Leppard

IRTC (US)
November 14, 2025

MMSI: Wrapsody Outpatient Margin Implications

•

John Leppard

MMSI (US)
November 13, 2025

GKOS: iDose Medicare Coverage Expectations

•

John Leppard

GKOS (US)
November 7, 2025

Obesity Drug Pricing Deal: Devil in the Details

•

John Leppard

CI (US), CNC (US), CVS (US), ELV (US), HUM (US), LLY (US), NVO (US), UNH (US)
November 5, 2025

[LLY, NVO] Obesity Rx Deal Expectations

•

John Leppard

LLY (US), NVO (US)
November 3, 2025

[MDXG, CTEC.LN, COLOB.C] Skin Substitute Rates & Additional Risks

•

John Leppard

CTEC (LSE), MDXG (US)
November 3, 2025

PRCT: Nominal Rates vs Opportunity Costs

•

John Leppard

BSX (US), PRCT (US), TFX (US)
October 31, 2025

Merit Medical (MMSI): Net vs List Price in Pass-Through Payments

•

John Leppard

MMSI (US)
October 29, 2025

[MDT, Otsuka] Renal Denervation: Broad Coverage, With New Guardrails

•

John Leppard

MDT (US), OTSKY (US)
October 27, 2025

GKOS: iDose Coverage Question Tea Leaves

•

John Leppard

GKOS (US)